NEUROBIOLOGICAL PREDICTORS of RESPONSE to DORSOLATERAL PREFRONTAL CORTEX REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION in DEPRESSION: A SYSTEMATIC REVIEW

Depression and Anxiety

Volumn 32, Issue 12, 2015, Pages 871-891

  Silverstein, William K ^a,b   Noda, Yoshihiro ^a   Barr, Mera S ^a,c   Vila Rodriguez, Fidel ^d   Rajji, Tarek K ^a,b,c   Fitzgerald, Paul B ^e   Downar, Jonathan ^a,b,f   Mulsant, Benoit H ^a,c   Vigod, Simone ^a,g   Daskalakis, Zafiris J ^a,b,c   Blumberger, Daniel M ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

neurobiological predictor; rTMS; treatment resistant depression

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HYDROCORTISONE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN; VALINE;

5 HYDROXYTRYPTAMINE 1A GENE; ALPHA RHYTHM; AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; BECK DEPRESSION INVENTORY; BETA RHYTHM; BIPOLAR DEPRESSION; BRAIN BLOOD FLOW; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; BRAIN SIZE; CINGULATE GYRUS; DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; ESTROGEN PROGESTERONE RATIO; EVOKED MUSCLE RESPONSE; FRONTAL LOBE; GENETIC POLYMORPHISM; HAMILTON DEPRESSION RATING SCALE; HIPPOCAMPUS; HOMOZYGOTE; HORMONE ACTION; HUMAN; INSULA; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROIMAGING; PRIORITY JOURNAL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SEROTONIN TRANSPORTER GENE; SYSTEMATIC REVIEW; TEMPORAL LOBE; THETA RHYTHM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; BLOOD FLOW VELOCITY; BRAIN CIRCULATION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; METABOLISM; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PROCEDURES; RETREATMENT; TREATMENT OUTCOME;

BLOOD FLOW VELOCITY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBROVASCULAR CIRCULATION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; RETREATMENT; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VALINE;

EID: 84949627535     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22424     Document Type: Article

References (65)

1. Murray CJ, Vos T, Lozano R, et al., Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223. [PubMed: 23245608]
2. Ferrari AJ, Charlson FJ, Norman RE, et al., Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 2013; 10: e1001547. [PubMed: 24223526]
3. Lepine JP, Briley M,. The increasing burden of depression. Neuropsychiatr Dis Treat 2011; 7: 3-7. [PubMed: 21750622]
4. Nemeroff CB., Prevalence and management of treatment-resistant depression. J Clin Psychiatry 2007; 68 (Suppl 8): 17-25.
5. Connolly KR, Helmer A, Cristancho MA, et al., Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry 2012; 73: e567-573. [PubMed: 22579164]
6. O'Reardon JP, Solvason HB, Janicak PG, et al., Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208-1216. [PubMed: 17573044]
7. George MS, Taylor JJ, Short EB,. The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry 2013; 26: 13-18. [PubMed: 23154644]
8. Schutter DJ., Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2009; 39: 65-75. [PubMed: 18447962]
9. Birkett MA, Day SJ,. Internal pilot studies for estimating sample size. Stat Med 1994; 13: 2455-2463. [PubMed: 7701146]
10. Julious SA., Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005; 4: 287-291.
11. Moore CG, Carter RE, Nietert PJ, et al., Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci 2011; 4: 332-337. [PubMed: 22029804]
12. Schoenfeld D., Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys 1980; 6: 371-374. [PubMed: 7390914]
13. Eschweiler GW, Wegerer C, Schlotter W, et al., Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiat Res Neuroim 2000; 99: 161-172. [PubMed: 11068197]
14. Hernandez-Ribas R, Deus J, Pujol J, et al., Identifying brain imaging correlates of clinical response to repetitive transcranial magnetic stimulation (rTMS) in major depression. Brain Stimul 2013; 6: 54-61. [PubMed: 22417767]
15. Kimbrell TA, Little JT, Dunn RT, et al., Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999; 46: 1603-1613. [PubMed: 10624541]
16. Paillere Martinot ML, Martinot JL, Ringuenet D, et al., Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation. Neuropsychopharmacology 2011; 36: 2710-2719. [PubMed: 21849980]
17. Zanardi R, Magri L, Rossini D, et al., Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression. Eur Neuropsychopharmacol 2007; 17: 643-650. [PubMed: 17466494]
18. Baeken C, De Raedt R, Vanderhasselt M, et al., A «hypersensitive» hypothalamic-pituitary-adrenal system could be indicative for a negative clinical high-frequency repetitive transcranial magnetic stimulation outcome in melancholic depressed patients. Brain Stimul 2010; 3: 54-57. [PubMed: 20633431]
19. Fitzgerald PB, Brown TL, Marston NAU, et al., Motor cortical excitability and clinical response to rTMS in depression. J Affect Disord 2004; 82: 71-76. [PubMed: 15465578]
20. Widge AS, Avery DH, Zarkowski P,. Baseline and treatment-emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation. Brain Stimul 2013; 6: 929-931. [PubMed: 23763894]
21. Krstic J, Buzadžic I, Milanovic SD, et al., Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial. J ECT 2014;Dec;30(4):325-331. [PubMed: 24625704]
22. Narushima K, McCormick LM, Yamada T, et al., Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. J Neuropsychiatry Clin Neurosci 2010; 22: 75-84. [PubMed: 20160213]
23. Speer AM, Benson BE, Kimbrell TK, et al., Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET. J Affect Disord 2009; 115: 386-394. [PubMed: 19027962]
24. Furtado CP, Hoy KE, Maller JJ, et al., Cognitive and volumetric predictors of response to repetitive transcranial magnetic stimulation (rTMS)-a prospective follow-up study. Psychiatry Res 2012; 202: 12-19. [PubMed: 22608156]
25. Pretalli JB, Nicolier M, Chopard G, et al., Resting motor threshold changes and clinical response to prefrontal repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Clin Neurosci 2012; 66: 344-352. [PubMed: 22624740]
26. Bocchio-Chiavetto L, Miniussi C, Zanardini R, et al., 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression. Neurosci Lett 2008; 437: 130-134. [PubMed: 18450378]
27. Kito S, Hasegawa T, Koga Y,. Cerebral blood flow in the ventromedial prefrontal cortex correlates with treatment response to low-frequency right prefrontal repetitive transcranial magnetic stimulation in the treatment of depression. Psychiatry Clin Neurosci 2012; 66: 138-145. [PubMed: 22353326]
28. O'Reardon JP, Cristancho P, Pilania P, et al., Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depress Anxiety 2007; 24: 537-544. [PubMed: 17131353]
29. Richieri R, Boyer L, Farisse J, et al., Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. Eur J Nucl Med Mol Imaging 2011; 38: 1715-1722. [PubMed: 21647787]
30. Arns M, Drinkenburg WH, Fitzgerald PB, et al., Neurophysiological predictors of non-response to rTMS in depression. Brain Stimul 2012; 5: 569-576. [PubMed: 22410477]
31. Huang CC, Wei IH, Chou YH, et al., Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology 2008; 33: 821-831. [PubMed: 18468810]
32. Kito S, Hasegawa T, Koga Y,. Cerebral blood flow ratio of the dorsolateral prefrontal cortex to the ventromedial prefrontal cortex as a potential predictor of treatment response to transcranial magnetic stimulation in depression. Brain Stimul 2012; 5: 547-553. [PubMed: 22019081]
33. Langguth B, Wiegand R, Kharraz A, et al., Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuroendocrinol Lett 2007; 28: 633-638. [PubMed: 17984932]
34. Malaguti A, Rossini D, Lucca A, et al., Role of COMT, 5-HT1A, and SERT genetic polymorphisms on antidepressant response to transcranial magnetic stimulation. Depress Anxiety 2011; 28: 568-573. [PubMed: 21449006]
35. Micoulaud-Franchi J-A, Richieri R, Cermolacce M, et al., Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive transcranial magnetic stimulation: a preliminary study. J Affect Disord 2012; 137: 156-160. [PubMed: 22244378]
36. Pallanti S, Di Rollo A, Antonini S, et al., Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response. Neuropsychobiology 2012; 65: 227-235. [PubMed: 22653158]
37. Weiduschat N, Dubin MJ,. Prefrontal cortical blood flow predicts response of depression to rTMS. J Affect Disord 2013; 150: 699-702. [PubMed: 23707032]
38. Li CT, Chen LF, Tu PC, et al., Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study. PLoS One 2013; 8: e70089. [PubMed: 23936378]
39. Baeken C, De Raedt R, Van Hove C, et al., HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectr 2009; 14: 439-448. [PubMed: 19890238]
40. Nadeau SE, McCoy KJ, Crucian GP, et al., Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 159-175. [PubMed: 12218709]
41. Zwanzger P, Baghai TC, Padberg F, et al., The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychoneuroendocrinology 2003; 28: 376-385. [PubMed: 12573303]
42. Baeken C, De Raedt R, Bossuyt A, et al., The impact of HF-rTMS treatment on serotonin2A receptors in unipolar melancholic depression. Brain Stimul 2011; 4: 104-111. [PubMed: 21511211]
43. Luborzewski A, Schubert F, Seifert F, et al., Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res 2007; 41: 606-615. [PubMed: 16600298]
44. Price GW, Lee JW, Garvey C, et al., Appraisal of sessional EEG features as a correlate of clinical changes in an rTMS treatment of depression. Clin EEG Neurosci 2008; 39: 131-138. [PubMed: 18751562]
45. Li C-T, Wang S-J, Hirvonen J, et al., Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J Affect Disord 2010; 127: 219-229.
46. Mottaghy FM, Keller CE, Gangitano M, et al., Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res 2002; 115: 1-14. [PubMed: 12165364]
47. Teneback CC, Nahas Z, Speer AM, et al., Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 1999; 11: 426-435. [PubMed: 10570754]
48. Kito S, Fujita K, Koga Y,. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression. Neuropsychobiology 2008; 58: 29-36. [PubMed: 18781088]
49. Kito S, Fujita K, Koga Y,. Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J Neuropsychiatry Clin Neurosci 2008; 20: 74-80. [PubMed: 18305287]
50. Takahashi S, Ukai S, Tsuji T, et al., Cerebral blood flow in the subgenual anterior cingulate cortex and modulation of the mood-regulatory networks in a successful rTMS treatment for major depressive disorder. Neurocase 2013; 19: 262-267. [PubMed: 22512803]
51. Furtado CP, Hoy KE, Maller JJ, et al., An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study. Brain Stimul 2013; 6: 346-354. [PubMed: 22784443]
52. Conca A, Di Pauli J, Beraus W, et al., Combining high and low frequencies in rTMS antidepressive treatment: preliminary results. Hum Psychopharmacol 2002; 17: 353-356. [PubMed: 12415555]
53. Oberlander TF, Gingrich JA, Ansorge MS,. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther 2009; 86: 672-677. [PubMed: 19890255]
54. Moher D, Liberati A, Tetzlaff J, et al., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097. [PubMed: 19621072]
55. Brunoni AR, Boggio PS, Fregni F,. Can the 'yin and yang' BDNF hypothesis be used to predict the effects of rTMS treatment in neuropsychiatry? Med Hypotheses 2008; 71: 279-282. [PubMed: 18434040]
56. Downar J, Daskalakis ZJ,. New targets for rTMS in depression: a review of convergent evidence. Brain Stimul 2013; 6: 231-240. [PubMed: 22975030]
57. Downar J, Geraci J, Salomons TV, et al., Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biol Psychiatry 2014; 76: 176-185. [PubMed: 24388670]
58. Arns M, Cerquera A, Gutiérrez RM, et al., Non-linear EEG analyses predict non-response to rTMS treatment in major depressive disorder. Clin Neurophysiol 2014; 125: 1392-1399. [PubMed: 24360132]
59. Erguzel TT, Ozekes S, Gultekin S, et al., Neural network based response prediction of rTMS in major depressive disorder using QEEG cordance. Psychiatry Investig 2015; 12: 61-65. [PubMed: 25670947]
60. Sheline YI, Price JL, Yan Z, et al., Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci USA 2010; 107: 11020-11025. [PubMed: 20534464]
61. Noda Y, Silverstein W, Barr MS, et al., Neurobiological mechanisms of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex in depression: a systematic review. Psychol Med 2015; Sep 9:1-22. [Epub ahead of print]. [pubmed: 26349810].
62. Baeken C, Marinazzo D, Wu GR, et al., Accelerated HF-rTMS in treatment-resistant unipolar depression: insights from subgenual anterior cingulate functional connectivity. World J Biol Psychiatry 2014; 15: 286-297. [PubMed: 24447053]
63. Singh B, Henneberger C, Betances D, et al., Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons. J Neurosci 2006; 26: 7189-7200. [PubMed: 16822976]
64. Tabata T, Kano M,. GABAB receptor-mediated modulation of metabotropic glutamate signaling and synaptic plasticity in central neurons. Adv Pharmacol 2010; 58: 149-173. [PubMed: 20655482]
65. Chen J, Zhou C, Wu B, et al., Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res 2013; 210: 1260-1264. [PubMed: 24113125]